Atherton-Fessler, S., Hannig, G., Piwnica-Worms, H., 1993. Reversible tyrosine phosphorylation and cell cycle control. Semin. Cell. Biol. 4, 433^
442.
Bailly, E., McCa¡rey, M., Touchot, N., Zahraoui, A., Goud, B., Bornens, M., 1991. Phosphorylation of two small GTP-binding proteins of the
Rab family by p34cdc2. Nature 350, 715^718.
Baldin, V., Ducommun, B., 1995. Subcellular localisation of human wee1 kinase is regulated during the cell cycle. J. Cell Sci. 108, 2425^2432.
Blangy, A., Lane, H.A., d'Herin, P., Harper, M., Kress, M., Nigg, E.A., 1995. Phosphorylation by p34cdc2 regulates spindle association of human
Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83, 1159^1169.
Born, T.L., Frost, J.A., Schonthal, A., Prendergast, G.C., Feramisco, J.R., 1994. c-Myc cooperates with activated Ras to induce the cdc2
promoter. Mol. Cell. Biol. 14, 5710^5718.
Braak, E., Braak, H., Mandelkow, E.M., 1994. A sequence of cytoskeleton changes related to the formation of neuro¢brillary tangles and neuropil
threads. Acta Neuropathol. 87, 554^567.
Buchkovich, K.J., Zi¡, E.B., 1994. Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells. Mol. Biol. Cell 5, 1225^1241.
Cans, C.D.B., Baldin, V., 1999. Proteasome-dependent degradation of human CDC25B phosphatase. Mol. Biol. Rep. 26, 53^57.
Davezac, N., Ducommun, B., Baldin, V., 2000. Role of CDC25 phosphatases in the control of proliferation. Pathol. Biol. (Paris) 48, 182^189.
Davis, F.M., Tsao, T.Y., Fowler, S.K., Rao, P.N., 1983. Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. USA 80, 2926^2930.
De Souza, C.P., Ellem, K.A., Gabrielli, B.G., 2000. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events. Exp.
Cell Res. 257, 11^21.
Ding, X.L., Husseman, J., Tomashevski, A., Nochlin, D., Jin, L.W., Vincent, I., 2000. The cell cycle Cdc25A tyrosine phosphatase is activated in
degenerating postmitotic neurons in Alzheimer's disease [in process citation]. Am. J. Pathol. 157, 1983^1990.
Dobashi, Y., Kudoh, T., Matsumine, A., Toyoshima, K., Akiyama, T., 1995. Constitutive overexpression of CDK2 inhibits neuronal di¡er- entiation of rat pheochromocytoma PC12 cells. J. Biol. Chem. 270, 23031^23037.
Ducommun, B., Brambilla, P., Felix, M.A., Franza, B.R., Jr., Karsenti, E., Draetta, G., 1991. cdc2 phosphorylation is required for its interaction
with cyclin. EMBO J. 10, 3311^3319.
Dunphy, W.G., Kumagai, A., 1991. The cdc25 protein contains an intrinsic phosphatase activity. Cell 67, 189^196.
Furukawa, Y., Terui, Y., Sakoe, K., Ohta, M., Kitagawa, S., Miura, Y., Saito, M., 1995. Over-expression and ampli¢cation of the CDC2 gene in
leukaemia cells. Br. J. Haematol. 90, 94^99.
Furukawa, Y., Iwase, S., Terui, Y., Kikuchi, J., Sakai, T., Nakamura, M., Kitagawa, S., Kitagawa, M., 1996. Transcriptional activation of the
cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J. Biol. Chem. 271, 28469^28477.
Galaktionov, K., Beach, D., 1991. Speci¢c activation of cdc25 tyrosine phosphatases by B-type cyclins : evidence for multiple roles of mitotic
cyclins. Cell 67, 1181^1194.
Gartner, U., Holzer, M., Arendt, T., 1999. Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neuro¢brillary
degeneration. Neuroscience 91, 1^5.
Gasparotto, D., Maestro, R., Piccinin, S., Vukosavljevic, T., Barzan, L., Sulfaro, S., Boiocchi, M., 1997. Overexpression of CDC25A and
CDC25B in head and neck cancers. Cancer Res. 57, 2366^2368.
Gautier, J., Matsukawa, T., Nurse, P., Maller, J., 1989. Dephosphorylation and activation of Xenopus p34cdc2 protein kinase during the cell
cycle. Nature 339, 626^629.
Girard, F., Strausfeld, U., Cavadore, J.C., Russell, P., Fernandez, A., Lamb, N.J., 1992. cdc25 is a nuclear protein expressed constitutively
throughout the cell cycle in nontransformed mammalian cells. J. Cell Biol. 118, 785^794.
Gould, K.L., Nurse, P., 1989. Tyrosine phosphorylation of the ¢ssion yeast cdc2+ protein kinase regulates entry into mitosis [see comments].
Nature 342, 39^45.
Hayes, T.E., Valtz, N.L., McKay, R.D., 1991. Downregulation of CDC2 upon terminal di¡erentiation of neurons. New Biol. 3, 259^269.
Heald, R., McLoughlin, M., McKeon, F., 1993. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated
Cdc2 kinase. Cell 74, 463^474.
Hernandez, S., Hernandez, L., Bea, S., Cazorla, M., Fernandez, P.L., Nadal, A., Muntane, J., Mallofre, C., Montserrat, E., Cardesa, A., Campo,
E., 1998. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res. 58, 1762^1767.
Ho¡mann, I., Clarke, P.R., Marcote, M.J., Karsenti, E., Draetta, G., 1993. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B
and its involvement in the self-ampli¢cation of MPF at mitosis. EMBO J. 12, 53^63.
Ho¡mann, I., Draetta, G., Karsenti, E., 1994. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13, 4302^4310.
Ho¡mann, I., Karsenti, E., 1994. The role of cdc25 in checkpoints and feedback controls in the eukaryotic cell cycle. J. Cell Sci. 18 (Suppl.), 75^79.
Husseman, J.W., Nochlin, D., Vincent, I., 2000. Mitotic activation : a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol. Aging 21, 815^828.
Izumi, T., Maller, J.L., 1993. Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell 4,
1337^1350.
Jin, P., Hardy, S., Morgan, D.O., 1998. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875^885.
Karlsson, C., Katich, S., Hagting, A., Ho¡mann, I., Pines, J., 1999. Cdc25B and Cdc25C di¡er markedly in their properties as initiators of mitosis.
J. Cell Biol. 146, 573^584.
Karsenti, E., Bravo, R., Kirschner, M., 1987. Phosphorylation changes associated with the early cell cycle in Xenopus eggs. Dev. Biol. 119, 442^
453.
Keyomarsi, K., Pardee, A.B., 1993. Redundant cyclin overexpression and gene ampli¢cation in breast cancer cells. Proc. Natl. Acad. Sci. USA 90,
1112^1116.
Kondratick, C.M., Vandre, D.D., 1996. Alzheimer's disease neuro¢brillary tangles contain mitosis-speci¢c phosphoepitopes. J. Neurochem. 67,
2405^2416.
Kranenburg, O., Scharnhorst, V., Van der Eb, A.J., Zantema, A., 1995. Inhibition of cyclin-dependent kinase activity triggers neuronal di¡er- entiation of mouse neuroblastoma cells. J. Cell Biol. 131, 227^234.
Krek, W., Nigg, E.A., 1991. Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells : evidence for a double
block to p34cdc2 kinase activation in vertebrates. EMBO J. 10, 3331^3341.
Kuang, J., Ashorn, C.L., Gonzalez-Kuyvenhoven, M., Penkala, J.E., 1994. cdc25 is one of the MPM-2 antigens involved in the activation of
maturation-promoting factor [published erratum appears in Mol. Biol. Cell 5 (1994) May, 611]. Mol. Biol. Cell 5 (5), 135^145.
Kumagai, A., Dunphy, W.G., 1992. Regulation of the cdc25 protein during the cell cycle in Xenopus extracts. Cell 70, 139^151.
Lee, M.H., Nikolic, M., Baptista, C.A., Lai, E., Tsai, L.H., Massague, J., 1996. The brain-speci¢c activator p35 allows Cdk5 to escape inhibition
by p27Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93, 3259^3263.
